🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: High-dosage COVID-19 Vaccine,Inactivated

Found 22 matching trials

Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19

PHASE1

This study is a randomized, double-blinded, and placebo-controlled phase Ia...

Status

Completed

Location

West China Second University Hospital, Sichuan University / West China women's and children's Hospital

Start Date

2020-05-15

Trial ID

NCT04412538

Treatments Being Tested

Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule Medium dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule Medium dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule Placebo on a 0- and 28-day schedule Placebo on a 0- and 14-day schedule

Study of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine Administered Either Concomitantly or Singly in Participants 65 Years of Age and Older Previously Vaccinated With a 2-dose Schedule of Moderna COVID-19 Vaccine

PHASE2

The main purpose of this Phase II study was to assess the safety and immuno...

Status

Completed

Location

Investigational Site Number :8400003

Start Date

2021-07-16

Trial ID

NCT04969276

Treatments Being Tested

Quadrivalent Inactivated Influenza High Dose COVID-19 mRNA Vaccine (nucleoside modified)

Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated Vaccine in Healthy Adults in in Hong Kong

PHASE2

This is a randomized, double-blinded, Phase IIb clinical trial of COVID-19 ...

Status

Withdrawn

Location

Gleneagles Hospital HongKong

Start Date

2022-02-10

Trial ID

NCT05254236

Treatments Being Tested

COVID-19 Vaccine (Vero Cell), Inactivated (Medium-dose)COVID-19 Vaccine (Vero Cell), Inactivated (High-dose)

A Phase 1 Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine

PHASE1

A randomised, blinded, parallel-controlled phase 1 clinical trial to evalua...

Status

Unknown

Location

Shulan (Hangzhou) Hospital

Start Date

2023-03-10

Trial ID

NCT06113744

Treatments Being Tested

Placebo COVID-19 Vaccine (Vero Cell) ,Inactivated COVID-19 mRNA Vaccine (ZSVG-02-O) 10 μg COVID-19 mRNA Vaccine (ZSVG-02-O) 30 μg COVID-19 mRNA Vaccine (ZSVG-02-O) 60 μg

Dose Finding Study to Evaluate The Safety, Tolerability and Immunogenicity of an Inactiviated, Adjuvanted SARS-CoV-2 Virus Vaccine Candidate Against Covid-19 in Healthy Subjects

PHASE1

A multicenter, 3-arm randomized dose finding study in the UK to evaluate sa...

Status

Completed

Location

Queen Elizabeth Hospital

Start Date

2020-12-16

Trial ID

NCT04671017

Treatments Being Tested

VLA2001

A Study to Evaluate Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19)

PHASE2

This study is a randomized, double-blinded, and placebo controlled phase Ⅱ ...

Status

Unknown

Location

Jiangsu Provincial Center for Diseases Control and Prevention

Start Date

2020-10-27

Trial ID

NCT04756323

Treatments Being Tested

medium dosage inactivated SARS-CoV-2 vaccine high dosage inactivated SARS-CoV-2 vaccine Placebo

Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-Dose Inactivated Influenza Vaccine in Adult Participants 50 Years of Age and Older

PHASE1

Study VBT00001 is planned to be a Phase 1/2, randomized, modified double-bl...

Status

Completed

Location

Simon Williamson Clinic - Birmingham- Site Number : 8400003

Start Date

2024-11-19

Trial ID

NCT06695117

Treatments Being Tested

IIV-HD rC19 (dose 1)IIV-HD + rC19 (dose 1)IIV-HD + rC19 (dose 2)IIV-HD + rC19 (dose 3)IIV-HD + rC19 (dose 4)Placebo (0.9% NaCl)

Effectiveness of the Adsorbed Vaccine COVID-19 (Coronavac) Among Education and Public Safety Workers With Risk Factors for Severity

PHASE4

This is a quasi-experimental study with risk-based allocation. Public secur...

Status

Unknown

Location

Escola Normal Superior - Universidade do Estado do Amazonas

Start Date

2021-03-18

Trial ID

NCT04789356

Treatments Being Tested

Adsorbed SARS-CoV-2 (inactivated) vaccine

Efficacy,Immunogenicity and Safety of COVID-19 Vaccine , Inactivated Booster Dose in Adults Aged 18 Years and Above

PHASE3

This is a multi-center, case-driven, randomized, double-blinded, and placeb...

Status

Withdrawn

Location

Multiple Locations

Start Date

2023-02-20

Trial ID

NCT05156632

Treatments Being Tested

Medium-dosage COVID-19 Vaccine,Inactivated High-dosage COVID-19 Vaccine,Inactivated Placebo-comparator group

Safety and Immunogenicity Study of Booster Vaccination With Medium-dosage or High-dosage SARS-CoV-2 Inactivated Vaccine for Prevention of COVID-19

PHASE4

This is a randomized, double-blinded, phase ⅠV clinical trial of SARS-CoV-2...

Status

Unknown

Location

Xinqi City Center for Disease Control and Prevention

Start Date

2021-12-17

Trial ID

NCT05079217

Treatments Being Tested

High-dosage SARS-CoV-2 vaccine Medium-dosage SARS-CoV-2 vaccine

Previous Next